Effects of Enhanced Recovery After Surgery (ERAS) on Perioperative Outcomes in Shoulder Arthroplasty

Alexander Wong, Hayden L. Hofmann, Gage Guerra, Jonathan L. Le, Zorawar Singh, Frank A. Petrigliano, Abdullah FoadCureus 2025 · DOI

TL;DR

This large-scale retrospective study demonstrates that implementing Enhanced Recovery After Surgery (ERAS) protocols significantly improves outcomes for shoulder replacements. Patients receiving high levels of ERAS care saw a 22% reduction in complications, a nearly 95% decrease in in-hospital mortality, and shorter hospital stays compared to those receiving standard care.

What Problem Does This Paper Address?

Total shoulder arthroplasty (TSA)—including both anatomic and reverse procedures—is one of the fastest-growing orthopedic surgeries, with volumes projected to increase by 235% by 2025. Despite this surge, standardized "fast-track" recovery protocols, known as ERAS, have lagged behind those established for hip and knee replacements.

ERAS is a multidisciplinary approach designed to minimize the physiological stress of surgery through better pain management, early movement, and reduced use of invasive tubes (like catheters). While ERAS is known to work in other fields, there has been minimal large-scale research confirming its efficacy specifically for shoulder surgery. This paper seeks to fill that gap by analyzing whether "more ERAS" actually leads to better patient outcomes in TSA.

Methods

The researchers conducted a retrospective analysis of the Premier Health Database, identifying 74,158 patients who underwent elective inpatient TSA between 2010 and 2015.

Because there is no "official" TSA ERAS protocol, the authors selected nine billable criteria that align with general ERAS principles:

  1. Regional anesthesia (nerve blocks)
  2. Multimodal analgesia (non-opioid pain relief)
  3. Postoperative nausea/vomiting (PONV) prophylaxis
  4. Venous thromboembolism (VTE) prophylaxis
  5. Early physical therapy (Day 0 or 1)
  6. Use of Tranexamic acid (TXA) to reduce blood loss
  7. Absence of a Foley catheter
  8. Absence of a wound drain
  9. Direct discharge to home

Patients were categorized into Low (<6 criteria), Medium (6 criteria), or High (>6 criteria) ERAS groups. The team used mixed-model logistic regressions to determine the relationship between these groups and perioperative outcomes.

Datasets

The study utilized the Premier Health Database (PHD), a massive US clinical database containing over 127 million inpatient visits. It represents approximately 25% of all US inpatient admissions across 1,113 hospitals, providing a geographically and demographically diverse sample.

Key Insights and Ideas

  • The "Dose-Response" Effect: The study found a clear correlation between the number of ERAS components implemented and the quality of recovery. "High ERAS" wasn't just slightly better; it was transformative for patient safety.
  • The Power of Omission: Some of the most effective ERAS components were simply not doing things. Avoiding Foley catheters and wound drains were among the most frequently applied and effective measures for reducing complications.
  • The Mortality Threshold: Using a Youden index, the researchers identified that receiving four or more ERAS criteria was the optimal cutoff point for predicting a significant reduction in in-hospital mortality.
  • Underutilization of Proven Tools: Interestingly, regional anesthesia and TXA—now considered gold standards—were the least frequently applied components during the study period (2010–2015), suggesting significant room for improvement in hospital protocols.

Key Results

The quantitative benefits for the "High ERAS" group compared to the "Low ERAS" group were stark:

  • Complications: 22% lower odds of experiencing any complication (OR 0.78).
  • Mortality: A massive reduction in in-hospital mortality (OR 0.054).
  • Blood Transfusions: 42% lower odds of needing a transfusion (OR 0.58).
  • Length of Stay (LOS): Average hospital stay dropped from 2.19 days to 1.84 days.
  • Predictive Power: The number of ERAS criteria received was a strong predictor of survival, with an Area Under the Receiver Operating Characteristic (AUROC) curve of 0.75 for in-hospital mortality.

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Nature: The study relies on historical billing data, which may not capture the full clinical picture or the exact timing of medication administration.
  • Billable Items Only: The analysis was limited to items that could be tracked via the "Chargemaster." It could not account for non-billable ERAS pillars like preoperative nutrition or patient education.
  • Weighting: The study treated all nine ERAS criteria as having equal weight, though some (like early mobilization) may be more impactful than others.

Future Work: The authors call for the creation of an official, standardized ERAS protocol specifically for shoulder arthroplasty. They also suggest that future studies should look at long-term outcomes, such as 90-day readmission rates and long-term joint function, rather than just the immediate perioperative period.

Summary updated

Abstract

Background and objective Enhanced Recovery After Surgery (ERAS) is a multidisciplinary, evidence-based management pathway to decrease length of stay (LOS) and complication rates. However, there is minimal research on ERAS regarding total shoulder arthroplasties (TSA). This study aimed to analyze the effects of the ERAS protocol on perioperative outcomes in patients who underwent elective, inpatient TSAs. Methods A retrospective analysis was conducted using the Premier Health Database. Patients who underwent an elective anatomic TSA (aTSA) or reverse TSA (rTSA) were categorized into 'Low ERAS', 'Medium ERAS', or 'High ERAS' based on the number of billable ERAS criteria. Mixed model logistic regressions yielded odds ratios (ORs) and 95% confidence intervals (CIs). An area under the receiver operating characteristic curve (AUROC) and a Youden index were calculated to determine the optimal cutoff point for the best predictive model. Results A total of 74,158 patients were identified. Of them, 15,285 (20.6%) patients were 'High ERAS', 21,809 (29.4%) were 'Medium ERAS', and 37,064 (50.0%) were 'Low ERAS.' 'High ERAS' patients had significantly decreased ORs of experiencing any complication (OR=0.78, p<0.001), cardiopulmonary complications (OR=0.75, p<0.001), in-hospital mortality (OR=0.054, p=0.0040), and blood transfusions (OR=0.58, p<0.0001), and a shorter LOS from 2.19 days to 1.84 days (p<0.0001). The AUROC for the number of ERAS criteria received and in-hospital mortality was 0.75 with an optimal cutoff point of four ERAS criteria. Conclusions TSAs are not an exception to the promising benefits of the ERAS protocol. Efforts should be made to create an official ERAS protocol in TSAs and help hospitals allocate resources to make its implementation possible.
BibTeX
@inproceedings{wong2025effects,
  author = {Alexander Wong and Hayden L. Hofmann and Gage Guerra and Jonathan L. Le and Zorawar Singh and Frank A. Petrigliano and Abdullah Foad},
  title = {{Effects of Enhanced Recovery After Surgery (ERAS) on Perioperative Outcomes in Shoulder Arthroplasty}},
  booktitle = {Cureus},
  year = {2025},
  doi = {10.7759/cureus.92284},
}
Figure